Chemours Company (The) (CC) Upgraded by BidaskClub to "Buy"

Thrivent Financial For Lutherans' holdings in Chemours Company (The) were worth $1,316,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in CC. Neuberger Berman Group LLC increased its stake in Chemours Company (The) by 1.5% in the first quarter. The stock has "Hold" rating by Jefferies on Thursday, September 1.

In the last reported quarter, Chemours Company reported its Actual EPS (earnings per share) of $0.75/share where most of the analysts working on this stock were estimating the EPS to be $0.5/share. Clean Yield Group acquired a new position in Chemours Company (The) during the first quarter worth approximately $167,000. Ameritas Investment Partners Inc. raised its position in Chemours Company (The) by 349.0% in the first quarter.

Chemours Company (NYSE:CC) opened at 44.76 on Friday. The stock had a trading volume of 1,864,132 shares. The company has market cap of $8.32 billion. Recently, the stock has been moved 11.67% from its 200-day simple moving average.

Analysts' mean recommendation for The Chemours Company (CC) stands at 1.90.

US based company, The Chemours Company (CC)'s latest closing price distance was 40.39% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at 4.08% and 10.31% compared with the 20 Day Moving Average. Analysts forecast earnings per share of $0.71, up exactly $0.44 or 162.96 % from 2014's $0.27 EPS.

Average Revenue Estimate for the current quarter is $1.51 Billion, according to consensus forecast of 4 analysts. Chemours Company (The) had a return on equity of 125.69% and a net margin of 1.91%. The business's quarterly revenue was up 10.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.06 EPS. Analysts predict that Chemours Company will post $3.27 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Thursday, June 15th. Shareholders of record on Wednesday, May 17th were given a $0.03 dividend. The ex-dividend date was Monday the 15th of May 2017. Chemours Company (The)'s payout ratio is now 22.22%.

COPYRIGHT VIOLATION WARNING: This article was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of United States & worldwide trademark & copyright legislation. The correct version of this piece can be accessed at https://www.chaffeybreeze.com/2017/07/16/chemours-company-the-nysecc-upgraded-by-citigroup-inc-to-buy-updated.html.

CC has been the subject of several other research reports. J P Morgan Chase & Co raised shares of Chemours Company (The) from a neutral rating to an overweight rating and lifted their price objective for the company from $39.00 to $50.00 in a research note on Friday, May 12th. ValuEngine raised Chemours Company (The) from a "hold" rating to a "buy" rating in a research report on Friday, June 2nd. BidaskClub lowered Chemours Company (The) from a "buy" rating to a "hold" rating in a research report on Saturday, June 17th. Citigroup Inc. raised Chemours Company (The) from a "neutral" rating to a "buy" rating and increased their price objective for the company from $43.00 to $45.00 in a report on Wednesday, July 5th. The company now has an average rating of "Buy" and an average target price of $39.71.

Among 8 analysts covering Chemours (NYSE:CC), 7 have Buy rating, 1 Sell and 0 Hold. The stock has a consensus rating of "Buy" and a consensus target price of $39.71.

In related news, Director Richard H. Brown acquired 2,500 shares of the company's stock in a transaction dated Wednesday, May 3rd. The shares were bought at an average price of $39.10 per share, with a total value of $97,750.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

In other news, insider Paul Kirsch sold 19,036 shares of the stock in a transaction dated Monday, June 5th. Separately, VP Corp Comm & CBO Parker Erich Sell 4908 shares of the company at a price of $45.53 on 2017-05-16. The disclosure for this sale can be found here. Insiders have sold 46,725 shares of company stock valued at $1,919,300 in the last quarter.

The Average Volume for 10 days is 2.65 Million for Chemours Company (NYSE:CC).

Latest News